StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 10/22/2013 -- StockRunway.com issues special report on -Fusion-IO, Inc.(NYSE:FIO), Eldorado Gold Corp (USA)(NYSE:EGO), Direxion Shares Exchange Traded Fund Trust(NYSEARCA:DUST), Depomed Inc(NASDAQ:DEPO)
Fusion-IO, Inc.(NYSE:FIO) decreased -4.46% at the price of $13.28 recently on a traded volume of 5.35 million shares, in comparison to 3.52 million shares of average trading volume. So far this year, the stock is down -42.22%.
The company has a total market capitalization of $1.35 Billion and its total outstanding shares are 102.32 million. Fusion-io, Inc. develops, markets, and sells storage memory platforms in the United States and internationally.
Has FIO Found The Bottom and Ready To Move Up? Find Out Here
Eldorado Gold Corp (USA)(NYSE:EGO) soared +3.80% at the trading price of $6.54 on a traded volume of 3.70 million shares till now, whereas its average trading volume is 7.26 million shares. In the last three months, the stock is down -16.13%. The Intra-day range for the stock is $6.45 and $6.68. Eldorado Gold Corporation, together with its subsidiaries, engages in the exploration, development, mining, and production of gold properties in Turkey, China, Greece, Brazil, and Romania.
For How Long EGO’s Gloss will Attract Investors? Find out via this report
Direxion Shares Exchange Traded Fund Trust(NYSEARCA:DUST) dropped down -12.10% at the $28.90 recently. So far in three months, the stock is down -21.96%. The 52-week range for the stock is $11.16 and $83.19. Its introductory price for the day was $30.66, with the overall traded volume of 526,290.00 shares.
Why Should Investors Buy DUST After the Recent Fall? Just Go Here and Find Out
Depomed Inc(NASDAQ:DEPO), after opening its shares at the price of $8.00, jumped up +5.95% , its recent trading price was $7.66 for the day. The stock moved on a traded volume of 2.20 million shares, in comparison to 301,536.00 shares of average trading volume.
The 52-week range for the stock is $4.99 and $8.05. Its introductory price for the day was $8.00. Depomed, Inc., a specialty pharmaceutical company, focuses on developing products for pain and other conditions, and diseases of the central nervous system in the United States.
Why Should Investors Buy DEPO After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)